A comprehensive view of respiratory/lung health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Japan joins US, EU in approving AstraZeneca’s injectable asthma drug Tezspire tezepelumab, developed with Amgen; Tezspire treats severe, refractory bronchial asthma that can't be controlled with inhaled corticosteroids, long-term maintenance therapies

GlaxoSmithKline Listed a New Clinical Trial to Study Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

Nanopharm, Fluidda partner to accelerate FDA approval of orally inhaled generic products to treat asthma, COPD; firms to use Nanopharm’s in vitro/in silico platform, Fluidda’s Functional Respiratory Imaging platform

Puma Biotechnology to license Japanese drug firm Takeda’s experimental oral drug alisertib used to treat breast and lung cancers in deal worth up to US$294.0M; Puma to be responsible for global development, commercialization of the drug

Monoclonal antibody mepolizumab reduces asthma exacerbations among urban youth, decreases asthma attacks by 27% in Black, Hispanic children with a form of severe asthma; CDC estimates 2.3 million children in US had an asthma attack in 2019: Lancet

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count